Treatment of Invasive Aspergillosis: How It’s Going, Where It’s Heading
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of Invasive Aspergillosis: How It’s Going, Where It’s Heading
Authors
Keywords
-
Journal
MYCOPATHOLOGIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-04-27
DOI
10.1007/s11046-023-00727-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Azole resistance in Aspergillus fumigatus . The first 2‐year's Data from the Danish National Surveillance Study, 2018–2020
- (2022) Malene Risum et al. MYCOSES
- Invasive candidiasis: Investigational drugs in the clinical development pipeline and mechanisms of action
- (2022) Martin Hoenigl et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Let's talk about sex characteristics—As a risk factor for invasive fungal diseases
- (2022) Matthias Egger et al. MYCOSES
- Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis
- (2022) Rainer Höhl et al. MYCOSES
- Case Report: Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral Mucormycosis
- (2022) Alexandra Serris et al. Frontiers in Immunology
- The Combination Treatment of Fosmanogepix and Liposomal Amphotericin B Is Superior to Monotherapy in Treating Experimental Invasive Mold Infections
- (2022) Teclegiorgis Gebremariam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation
- (2022) Lisa Kriegl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds
- (2022) Beeke Tappe et al. Frontiers in Immunology
- COVID-19-associated fungal infections
- (2022) Martin Hoenigl et al. Nature Microbiology
- Pharmacodynamics, Mechanisms of Action and Resistance, and Spectrum of Activity of New Antifungal Agents
- (2022) Nathan P. Wiederhold Journal of Fungi
- CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models
- (2022) Michelle Seif et al. Science Translational Medicine
- Vaccination with Live or Heat-Killed Aspergillus fumigatus Δ sglA Conidia Fully Protects Immunocompromised Mice from Invasive Aspergillosis
- (2022) Caroline Mota Fernandes et al. mBio
- Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study
- (2022) Simon Feys et al. Lancet Respiratory Medicine
- Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections
- (2022) David A. Angulo et al. Journal of Fungi
- Nivolumab and interferon-γ rescue therapy to control mixed mould and bacterial superinfection after necrotizing fasciitis and septic shock
- (2022) Anne-Claire Lukaszewicz et al. Medical Mycology Case Reports
- Liposomal amphotericin B—the future
- (2022) M Hoenigl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A B1a–natural IgG–neutrophil axis is impaired in viral- and steroid-associated aspergillosis
- (2022) Nicole Sarden et al. Science Translational Medicine
- Editorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Fungal Pathogens During the COVID-19 Pandemic
- (2022) Dinah V. Parums MEDICAL SCIENCE MONITOR
- Surfactant protein D inhibits growth, alters cell surface polysaccharide exposure and immune activation potential of Aspergillus fumigatus
- (2022) Sarah Sze Wah Wong et al. Cell Surface
- Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
- (2021) Johan A Maertens et al. LANCET
- Vaccine-Induced Protection in Two Murine Models of Invasive Pulmonary Aspergillosis
- (2021) Emily Rayens et al. Frontiers in Immunology
- Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole
- (2021) Malene Risum et al. Antibiotics-Basel
- In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of Aspergillus, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies
- (2021) Olga Rivero-Menendez et al. Journal of Fungi
- In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents
- (2021) Ourania Georgacopoulos et al. Journal of Fungi
- Antifungals in Clinical Use and the Pipeline
- (2021) Melissa D. Johnson INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Stable prevalence of triazole-resistance in Aspergillus fumigatus complex clinical isolates in a Belgian tertiary care center from 2016 to 2020
- (2021) Agustin Resendiz-Sharpe et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Aspergillus fumigatus and aspergillosis: From basics to clinics
- (2021) A. Arastehfar et al. STUDIES IN MYCOLOGY
- Antifungal Pipeline
- (2021) Todd Patrick McCarty et al. Frontiers in Cellular and Infection Microbiology
- Emergence of Triazole Resistance in Aspergillus spp. in Latin America
- (2021) Daiana Macedo et al. Current Fungal Infection Reports
- The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
- (2021) Martin Hoenigl et al. DRUGS
- Defective Interferon-Gamma Production Is Common in Chronic Pulmonary Aspergillosis
- (2021) Stefano A P Colombo et al. JOURNAL OF INFECTIOUS DISEASES
- Management of drug–drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs
- (2021) Roger J Brüggemann et al. Lancet Haematology
- The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles
- (2021) Andrzej Czyrski et al. Pharmaceutics
- Anidulafungin and Micafungin concentrations in Cerebrospinal Fluid and in Cerebral Cortex
- (2020) Jana Marx et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PD-1 blockade improves survival and fungal clearance, induces pro-inflammatory lung cytokines and synergizes with caspofungin in a pulmonary aspergillosis model
- (2020) Sebastian Wurster et al. JOURNAL OF INFECTIOUS DISEASES
- Interferon gamma replacement as salvage therapy in chronic pulmonary aspergillosis: effects on frequency of acute exacerbation and all-cause hospital admission
- (2020) Edward J M Monk et al. THORAX
- Screening for triazole resistance in clinically significant Aspergillus species; report from Pakistan
- (2020) Safia Moin et al. Antimicrobial Resistance and Infection Control
- Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation
- (2020) A. Gómez-López CLINICAL MICROBIOLOGY AND INFECTION
- In vitro activity of olorofim (F901318) against fungi of the genus, Scedosporium and Rasamsonia as well as against Lomentospora prolificans, Exophiala dermatitidis and azole-resistant Aspergillus fumigatus
- (2020) Lisa Kirchhoff et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations
- (2020) Christoph Zurl et al. Journal of Fungi
- Epidemiology of invasive fungal disease in haematologic patients
- (2020) Luciana Souza et al. MYCOSES
- Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent
- (2020) Lindsey Cass et al. Pharmacology Research & Perspectives
- Prospective multicenter surveillance of clinically isolated Aspergillus species revealed azole-resistant Aspergillus fumigatus isolates with TR34/L98H mutation in the Kyoto and Shiga regions of Japan
- (2019) Yasuhiro Tsuchido et al. MEDICAL MYCOLOGY
- Invasive Aspergillosis in Solid Organ Transplant Recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
- (2019) Shahid Husain et al. CLINICAL TRANSPLANTATION
- Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy
- (2019) E Furfaro et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nonrandom Distribution of Azole Resistance across the Global Population of Aspergillus fumigatus
- (2019) Thomas R. Sewell et al. mBio
- Blockade of PD-1 Attenuated Post-Sepsis Aspergillosis via The Activation Of IFN-γ and The Dampening of IL-10
- (2019) Chau Tran Bao Vu et al. SHOCK
- Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection
- (2019) Thomas Colley et al. Scientific Reports
- Antifungal prophylaxis with posaconazole tablet and oral suspension in patients with haematologic malignancy: Therapeutic drug monitoring, efficacy and risk factors for the suboptimal level
- (2019) Jihyu Oh et al. MYCOSES
- A Heat-Killed Cryptococcus Mutant Strain Induces Host Protection against Multiple Invasive Mycoses in a Murine Vaccine Model
- (2019) Yina Wang et al. mBio
- Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013
- (2019) Maxime Parent-Michaud et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model
- (2018) Miao Zhao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Prophylaxis with Posaconazole Delayed-Release Tablet and Oral Suspension in a Real-Life Setting: Plasma Levels, Efficacy, and Tolerability
- (2018) David Lenczuk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials
- (2018) David Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology and Outcomes of Hospitalizations With Invasive Aspergillosis in the United States, 2009–2013
- (2018) Marya D Zilberberg et al. CLINICAL INFECTIOUS DISEASES
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
- (2018) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates
- (2018) Jessica J Talbot et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OUP accepted manuscript
- (2018) MEDICAL MYCOLOGY
- The diagnosis and treatment of invasive aspergillosis in Dutch haematology units facing a rapidly increasing prevalence of azole-resistance. A nationwide survey and rationale for the DB-MSG 002 study protocol
- (2018) Alexander F. A. D. Schauwvlieghe et al. MYCOSES
- Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
- (2018) Jeffrey D Jenks et al. Drug Design Development and Therapy
- High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardio-thoracic centre
- (2018) Alireza Abdolrasouli et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management
- (2018) Pieter P.A. Lestrade et al. CLINICAL MICROBIOLOGY AND INFECTION
- Posaconazole liquid vs tablet formulation in lung transplant recipients
- (2017) D. Stelzer et al. MYCOSES
- Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus Isolates from China
- (2016) Yong Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels
- (2016) Jürgen Prattes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults
- (2016) Taylor Sandison et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Delay of antifungal therapy influences the outcome of invasive aspergillosis in experimental models of infection
- (2016) Francesco Barchiesi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
- (2016) Haiying Jin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Role of Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Regulating Neutrophil Antifungal Activity and the Oxidative Burst During Respiratory Fungal Challenge
- (2016) Shinji Kasahara et al. JOURNAL OF INFECTIOUS DISEASES
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
- (2016) Johan A Maertens et al. LANCET
- Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis
- (2016) Laiza M. Steimbach et al. MYCOSES
- Correction: Galactomannan Testing and the Incidence of Invasive Pulmonary Aspergillosis: A 10-Year Nationwide Population-Based Study in Taiwan
- (2016) Kuo-Shao Sun et al. PLoS One
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Combination Antifungal Therapy for Invasive Aspergillosis
- (2015) Kieren A. Marr et al. ANNALS OF INTERNAL MEDICINE
- International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus
- (2015) Paul E. Verweij et al. DRUG RESISTANCE UPDATES
- High prevalence of azole resistance inAspergillus fumigatusisolates from high-risk patients
- (2015) J. Fuhren et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial
- (2015) Liping Wan et al. JOURNAL OF CLINICAL ONCOLOGY
- Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series
- (2014) Corine E Delsing et al. BMC INFECTIOUS DISEASES
- Clinically relevant drug–drug interactions between antiretrovirals and antifungals
- (2014) Ramya Krishna Vadlapatla et al. Expert Opinion on Drug Metabolism & Toxicology
- Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies
- (2014) Martin Hoenigl et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Micafungin for the treatment of invasive aspergillosis
- (2014) D.A. Enoch et al. JOURNAL OF INFECTION
- Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies
- (2013) Martin Hoenigl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
- (2013) Richard J. Hamill DRUGS
- Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)
- (2013) M. T. Montagna et al. INFECTION
- Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis
- (2013) John W. Baddley et al. MEDICAL MYCOLOGY
- Vaccination with mannan protects mice against systemic aspergillosis
- (2012) Min Liu et al. MEDICAL MYCOLOGY
- Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis
- (2011) O. A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis
- (2011) S. Schwartz et al. INFECTION
- Phototoxicity and photocarcinogenesis associated with voriconazole
- (2011) O. Epaulard et al. MEDECINE ET MALADIES INFECTIEUSES
- Exogenous Interferon-γ Immunotherapy for Invasive Fungal Infections in Kidney Transplant Patients
- (2010) D. Armstrong-James et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study
- (2010) R Herbrecht et al. BONE MARROW TRANSPLANTATION
- Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)
- (2010) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation
- (2010) Víctor Monforte et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Management of Drug and Food Interactions with Azole Antifungal Agents in Transplant Recipients
- (2010) Elizabeth Dodds-Ashley PHARMACOTHERAPY
- Anti-Aspergillushuman host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity
- (2009) Louis Y. A. Chai et al. IMMUNOLOGY
- An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients
- (2009) C. Viscoli et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety
- (2009) Víctor Monforte et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Exogenous Pentraxin 3 Restores Antifungal Resistance and Restrains Inflammation in Murine Chronic Granulomatous Disease
- (2009) C. D'Angelo et al. JOURNAL OF IMMUNOLOGY
- Immune Sensing of Aspergillus fumigatus Proteins, Glycolipids, and Polysaccharides and the Impact on Th Immunity and Vaccination
- (2009) S. Bozza et al. JOURNAL OF IMMUNOLOGY
- Randomized phase III study of granulocyte transfusions in neutropenic patients
- (2008) M G Seidel et al. BONE MARROW TRANSPLANTATION
- Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy
- (2008) Ray Y. Hachem et al. CANCER
- Hallucinations during Voriconazole Therapy
- (2008) Dimitrios I. Zonios et al. CLINICAL INFECTIOUS DISEASES
- Interferon-γ and Granulocyte-Macrophage Colony Stimulating Factor Therapy in Three Patients with Pulmonary Aspergillosis
- (2008) A. Bandera et al. INFECTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now